These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6149815)

  • 1. [Our first experimental and clinical experience with the neuroleptic isofloxythepin].
    Náhunek K; Svestka J; Cesková E; Rysánek R
    Cesk Psychiatr; 1984 Aug; 80(4):220-3. PubMed ID: 6149815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effectiveness of isofloxythepin--an open study].
    Zapletálek M; Tůma I; Kudrnová K
    Cesk Psychiatr; 1985 Aug; 81(4):242-6. PubMed ID: 2864141
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled cross-over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses.
    Svestka J; Náhunek K; Cesková E; Rysánek R; Balsíková J
    Act Nerv Super (Praha); 1989 Apr; 31(1):32-4. PubMed ID: 2571218
    [No Abstract]   [Full Text] [Related]  

  • 4. Further clinical experience with oxyprothepin-decanoate.
    Kalvach Z; Hálková E; Bastecký J
    Act Nerv Super (Praha); 1981 Dec; 23(4):271-2. PubMed ID: 6121440
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with the neuroleptic zotepine--first results.
    Haug HJ
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):35-7. PubMed ID: 2883679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isofloxythepine in an open study.
    Papezová H; David I; Alda M; Soucek R
    Act Nerv Super (Praha); 1989 Jun; 31(2):121-2. PubMed ID: 2572133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oxyprothepin decanoate in maintenance therapy of schizophrenia--a double-blind, standardized controlled study].
    Filip V; Faltus F; Hanáková S; Janecková E; Raboch J; Dobiásová A; Karen P; Posmurová M
    Cesk Psychiatr; 1985 Feb; 81(1):6-14. PubMed ID: 2858269
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of oxyprothepin decanoate (author's transl)].
    Kabes J; Balon R; Hanzlícek L; Skovajsová M; Kozáková H
    Cesk Psychiatr; 1980 Feb; 76(1):16-25. PubMed ID: 6103755
    [No Abstract]   [Full Text] [Related]  

  • 9. [Body weight increase: a side effect of zotepin (Nipolept)?].
    Wetterling T; Müssigbrodt H
    Nervenarzt; 1996 Mar; 67(3):256-61. PubMed ID: 8901286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isofloxythepin in restless oligophrenic children.
    Zapletálek M; Hametová M; Rýdlová E
    Act Nerv Super (Praha); 1989 Dec; 31(4):265. PubMed ID: 2576920
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric pharmacotherapy and the schizophrenic defect.
    Molcan J; Floreánová L; Novotný V; Polák L; Rakús A; Motýlová A
    Act Nerv Super (Praha); 1973 May; 15(2):91. PubMed ID: 4148088
    [No Abstract]   [Full Text] [Related]  

  • 13. [Zotepin--its value and potentials for further development].
    Nervenarzt; 1994 Jul; 65(7 Suppl):1-8. PubMed ID: 9218060
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual evoked potentials during the treatment with isofloxythepine.
    Libiger J; Kuba M; Zapletálek M; Dostál J
    Act Nerv Super (Praha); 1989 Apr; 31(1):34-5. PubMed ID: 2571219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of isofloxythepin].
    Pogády J; Martisová D; Varecka L
    Bratisl Lek Listy; 1988 Feb; 89(2):67-70. PubMed ID: 2896066
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of negative symptoms in schizophrenia with zotepine.
    Barnas C; Stuppaeck C; Unterweger B; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1987 Oct; 7(5):370-1. PubMed ID: 2890673
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
    Hashimoto K; Sudo T; Hirano M; Motomura H; Tagawa K; Nashiro S; Uemura K; Yoshimoto S
    Schizophr Res; 2006 Oct; 87(1-3):332-3. PubMed ID: 16797164
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intraindividual comparison of haloperidol decanoate and oxyprothepine in maintenance therapy in schizophrenic psychoses].
    Cesková E; Svestka J; Rysánek R
    Cesk Psychiatr; 1993 Jan; 89(1):11-4. PubMed ID: 8099534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia.
    Lawrie S; McIntosh A; Nadeem Z
    Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.